02-716-5977 info@tsh.or.th
Member Login | TH EN

เอกสารประกอบการประชุมประจำปีสมาคมโลหิตวิทยาแห่งประเทศไทย ครั้งที่ 65

18 มีนาคม 2568

00 กำหนดการประชุมวิชาการประจำปี

01 หนังสืองานประชุม

เอกสารประกอบแต่ละ Session

ปาฐกาสุภา ณ นคร - นพ.พลภัทร โรจนครินทร์

Memorial Lecture - นพ.กิตติ ต่อจรัส

Presidential Symposium - นพ.ธีระ ฤชุตระกูล

S01.1 CAR T-cell therapy for DLBCL  -พญ.จักราวดี จุฬามณี

S01.2 SOS prophylaxis and treatment - พญ.พิมพ์ใจ นิภารักษ์

S01.3 How to define graft failure and treatment - นพ.เจน เจิดอาไพ

S02.1 TKI switching in CML patient: from practice guidelines to real life - นพ.ต้นตนัย นาเบญจพล

S02.2 Breaking Free: When and how to stop tyrosine kinase inhibitors in CML - นพ.เอกพันธ์ ครุพงศ์

S03.1 Comprehensive geriatric assessment and clinical outcomes in elderly patients with acute leukemia -นพ.วีรภัทร โอวัฒนาพานิช

S03.2 The outcome of AML by ELN risk stratification in real practice - พญ.จันทิญา จันทร์สว่างภูวนะ

S03.3 Pre-transplant management: Enhancing ALL patient outcomes - นพ.ธนาวัฒก์ รัตนธรรมเมธี

S04.1 Key changes in 2025 TSH Thalassemia Management Guideline - พญ.เดือนธิดา ทรงเดช

S04.2 Ferroptosis: Roles in pathogenesis and treatment - นพ.ศิริชัย ศรีชัยรัตนกุล

S04.3 Unveiling KLF1 mutations in adult hemolytic anemia - พญ.ณัฐติยา เตียวตระกูล

S05.1 Oral metronomic chemotherapy in pediatric cancers - นพ.ปิติ เตชะวิจิตร์

S05.2 Nutritional challenges in childhood cancers - พญ.คุณัญญา สุวรรณยิ่ง

S05.3 Update in pediatric hemophagocytic lymphohistiocytosis - พญ.ชาลินี มนต์เสรีนุสรณ์

S06.1 Comprehensive care for AML patients: Role of nursing - พว.ธิดารัตน์ พิเชษฐวณิชย์โชค

S06.2 Bone marrow transplantation - พว.นุชจรี พูลมี

S06.3 Hemophilia - พว.เกศสุดา แคมพ์กา

S07.1 The shifting paradigm of treatment of mantle cell lymphoma: From chemotherapy to targeted therapies - พญ.ลลิตา นรเศรษฐ์ธาดา

S07.2 Waldenstrom macroglobulinemia - นพ.อาจรบ คูหาภินันทน์

S07.3 Shifting landscape of treatment in marginal zone lymphoma - นพ.กานดิษฏ์ ประยงค์รัตน์

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
E-Poster

PP-01  Clinical parameter and prognosis of subtyping diffuse large B-cell lymphoma with cell-of-origin
Nisa Makruasi

PP-02    Effects of nutritional status on academic achievement among children with thalassemia at Phramongkutklao Hospital
Panchalee Poovichayasumlit

PP-03    The accuracy of a point-of-care coagulation testing in pediatrics
Supicha Maneekhiew

PP-04    The association of HLA-B*5801 genotype and skin reactions among pediatric patients diagnosed with hematologic diseases and cancers receiving allopurinol
Parisa Maneechai

PP-05    Clinical outcomes in pediatric patients with severe aplastic anemia treated with Thai guideline
Nachapol Jatuten

PP-06    Clinical outcomes of pediatric osteosarcoma: Single center study
Patpetra Svasdisant

PP-07    Outcome of flag with or without idarubicin regimen in children with refractory or relapsed acute leukemia: A single center retrospective study
Achiraya Neatpracha

PP-08    Efficacy and safety of three-factor prothrombin complex concentrates for the management of oral direct factor XA inhibitor-associated major bleeding
Pakpoom Rasmeehirun

PP-09    Incidence of osteoporosis in steroid therapy in patients with lymphoma: A prospective single-center cohort study
Wichuporn Sirikajornroj

PP-10    Effect of time interval from diagnosis to treatment for diffuse large b-cell lymphoma (DLBCL) on survival: A retrospective single-centre cohort study
Auchariwan Saensen

PP-11    Prognostic outcomes of diffuse large B-cell lymphoma patients with myelocytomatosis oncogene (MYC) and B-cell lymphoma 2 (BCL2) co-expressor
Supanut Kumjan

PP-12    Incidence and risk factors of diabetes mellitus in patients with newly diagnosed Non-Hodgkin lymphoma (NHL) treated with CHOP based regimen
Preedee Patipanboonnum

PP-13    Prevalence of iliac compression syndrome in patients with deep vein thrombosis of the legs in Thais
Hathamon Chonwarangkoon

PP-14    Hemostatic changes and complications in patient undergoing extracorporeal mechanical membrane oxygenation: A prospective study in Thailand
Nutcha Pattaraarayakul.

PP-15    Gene mutation associated with hemolytic anemia in myelodyplastic syndrome
Nasawan Ratinanthakul

PP-16    Clinical outcomes of venous thromboembolism in patients with hepatobiliary and pancreatic cancer in Thailand: A retrospective cohort study
Yanisa Boonyayoi

PP-17    Post-treatment cognitive function and quality of life assessment comparing between primary central nervous system lymphoma and non-CNS lymphoma patients in complete remission
Warayoot Luangmaneerote

PP-18    Optimizing markers for chronic lymphocytic leukemia diagnosis by flow cytometry: Results from the nationwide Thai Lymphoma Study Group
Ornnicha Sathitakorn

PP-19    Genetic signatures and treatment outcomes in acute myeloid leukemia with hyperleukocytosis: A comprehensive analysis of 444 patients
Nattanon Namjuntra

PP-20    Bleeding and thrombosis in patients with suspected or confirmed heparin-induced thrombocytopenia: A 20-year experience at Siriraj Hospital
Yotsathon Chantarawichian

PP-21    Rate of advance care planning in refractory or early relapsed aggressive B-cell non-Hodgkin lymphoma and classical Hodgkin lymphoma at Siriraj Hospital
Jirapa Puriwekin

PP-22    Thrombin generation assay changes after prothrombin complex concentrates reversal in patient receiving direct oral anticoagulants
Decharawee Nuntadee

PP-23    Comparison of genetic profiling between myelodysplastic syndrome (MDS) and pre-MDS patients and the study of genetic mutation predicting response to low-dose erythropoietin therapy
Wichittraphon Sukcharoen

PP-24    Disease characteristics and treatment response in plasma cell disorders  patients based on genetic abnormalities from fluorescense in situ hybridization
Watcharamon Theerabunyakul

PP-25    Is bone marrow biopsy needed for diagnosis of acute leukemia?
Supakarn Boonnumma

PP-26    Prevalence and clinicopathologic characteristics according to cell of origin subtypes among patients with peripheral T cell lymphoma
Phartsakorn Charoensaksawan

PP-27    Associations of markers of coagulation, fibrinolysis and inflammation with post thrombotic syndrome
Worapapas Chalermsuwiwattanakan

PP-28    Generation of immortalized erythroid progenitor cell line from hematopoietic stem cells derived from β0-thalassemia (CODONS 41/42) with hemoglobin E disease
Thaw Naing Zin

  ข่าวและกิจกรรม